Robert Friel, John Roush, Martina Bielefeld-Sévigny, George Adam, Arnold Levine, William Longfield, Eric Setzer, Gary Boch, Jim Sheridan, John Elling, Robert Corn | GenomeWeb
As part of a realignment of its business into two segments — Human Health and Environmental Health — PerkinElmer said this week that Robert Friel, president and CEO, will lead the Human Health business on an interim basis and John Roush, who currently leads the company’s Optoelectronics business, will lead the Environmental Health division.
The realignment will go into effect on Jan. 1, 2009.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.